Aravive To Participate in the Jefferies Global Healthcare Co

HOUSTON, June 05, 2023 -- Aravive, Inc. , a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease today announced that Gail McIntyre, Ph.D., DABT,... | June 5, 2023

Related Keywords

Texas , United States , New York , Houston , Gail Mcintyre , Trudy Howard , Corey Davis , Nasdaq , Cancer Prevention Research Institute Of Texas , Lifesci Advisors , Aravive Inc , Globenewswire Inc , European Commission , Company Presentation , Product Development Award , Chief Executive Officer , Chief Financial Officer , Global Healthcare Conference , Click Here , Fast Track Designation , Orphan Drug Designation , Research Institute , Relations Contact , Sci Advisors , Aravive , Nc Stock Exchange , News , Information , Press Release , Pune , 023 , Gate , Ncology , Company , Developing , Argeted , Herapeutics , O , Treat , Metastatic , Disease , Oday , Nnounced , Hat , Ail Arav Us03890d1081 ,